Health Related Quality of Life in Thyroid Cancer Patients, and in Patients With Thyroid Nodules Suspicious of Cancer

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: Most patients with thyroid cancer have a long life expectancy, and it has been assumed among health professionals that therefore the quality of life (QOL) is good. Some European studies have shown that the quality of life among thyroid cancers is worse than the general population, and almost as low as other cancer diagnoses, with a worse prognosis and a more burdening treatment. Aim: To examine prospectively the quality of life in participants undergoing diagnostic thyroid surgery and participants undergoing surgery for certain thyroid cancer. By examining both groups we wish to find answers if quality of life is affected, and if so - mostly affected by the diagnosis or the surgery itself.

Methods: Participants enroll the study after informed consent, and quality of life will be assessed using quality of life questionnaires EORTC QLQ C30, EORTC THY 47 and EORTC FA12 before surgery, and 6 and 12 months after surgery. This study will form two main groups of participants; with and without thyroid cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• planned hemi- or total thyroidectomy at the ENT-Department of Oslo University Hospital

• tumour in the thyroid gland With fine needle aspiration results of Bethesda 3-6, or other clinical manifestations suspicious of cancer.

• ability to understand and Complete the quesitionnaires

• informed consent to participation

Locations
Other Locations
Norway
ENT department, Oslo University Hospital
RECRUITING
Oslo
Contact Information
Primary
Bianca MR Lorntzsen, MD
b.m.lorntzsen@medisin.uio.no
+4790087002
Backup
Terje A Osnes, MD, PhD
terje.osnes@medisin.uio.no
+4723071784
Time Frame
Start Date: 2018-01-25
Estimated Completion Date: 2028-04
Participants
Target number of participants: 200
Related Therapeutic Areas
Sponsors
Leads: Oslo University Hospital

This content was sourced from clinicaltrials.gov